Blue Earth Diagnostics Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$466M
Blue Earth Diagnostics General Information
Description
Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions. The company imaging agents can be used for PET imaging to detect and localize prostate cancer in men with the diagnosis of biochemical recurrence as well as in amino acid transport and radiopharmaceutical therapies, enabling medical practitioners to diagnose and treat brain and prostate cancer patients with improved efficiency.
Contact Information
Website
www.blueearthdiagnostics.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- The Oxford Science Park
- Magdalen Centre, Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
+44 01865 000000
Blue Earth Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Aug-2019 | $466M | 000.00 | 00000 | Completed | Profitable |
| 1. Early Stage VC | 11-Mar-2014 | 000.00 | 000.00 | Completed | Startup |
Blue Earth Diagnostics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions.
Drug Discovery
Oxford, United Kingdom
100
As of 2019
000.00
0000
0000-00-00
000000&0
000.00
000000
eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
Inglewood, CA
00
As of 0000
000.00
00000000000
000.00
000000
ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000 000000000
Eveleigh, Australia
00
As of 0000
00000
0000
0000-00-00
00000000
00000
Add Comparison
Blue Earth Diagnostics Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImaginAb | Venture Capital-Backed | Inglewood, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Formerly VC-backed | Eveleigh, Australia | 00 | 00000 | 00000000 | 00000 |
| 000000 0000000 | Formerly VC-backed | Richland, WA | 00 | 000.00 | 00000000 | 000.00 |
| 000 00000000 00000 | Private Equity-Backed | Munich, Germany | 000 | 00000 | 000000000000 | 00000 |
| 0-0000 | Venture Capital-Backed | Shilat, Israel | 00 | 0000 | 0000000000 0 | 0000 |
Blue Earth Diagnostics Patents
Blue Earth Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210290783-A1 | Imaging of metastatic or recurrent cancer | Pending | 30-Dec-2015 | 00000000000 | |
| US-20190105411-A1 | Imaging of metastatic or recurrent cancer | Granted | 30-Dec-2015 | 00000000000 | |
| US-20170189565-A1 | Imaging of metastatic or recurrent cancer | Granted | 30-Dec-2015 | 00000000000 | |
| US-20200316227-A1 | Imaging of metastatic or recurrent cancer | Granted | 30-Dec-2015 | 00000000000 | |
| US-10933147-B2 | Imaging of metastatic or recurrent cancer | Active | 30-Dec-2015 | A61K51/0402 | 0 |
Blue Earth Diagnostics Executive Team (17)
Blue Earth Diagnostics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Elisa Petris Ph.D | Syncona | Board Member | 000 0000 |
| Jonathan Allis Ph.D | Blue Earth Diagnostics | Chairman | 000 0000 |
| Martin Murphy Ph.D | Self | Chairman | 000 0000 |
Blue Earth Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
